These data support known protumorigenic roles for the VEGF-NRP1 signaling axis, ALCAM, and PDGFRB in GBM and other tumors, including in therapy-resistant tumor cell subsets that are likely to be enriched for TICs (56–64). This evidence concerns the gene ALCAM and neoplasm.